Literature DB >> 18310474

Cannabinoids inhibit network-driven synapse loss between hippocampal neurons in culture.

Hee Jung Kim1, Jonathan J Waataja, Stanley A Thayer.   

Abstract

Dendritic pruning and loss of synaptic contacts are early events in many neurodegenerative diseases. These effects are dynamic and seem to differ mechanistically from the cell death process. Cannabinoids modulate synaptic activity and afford protection in some neurotoxicity models. We investigated the effects of cannabinoids on activity-induced changes in the number of synapses between rat hippocampal neurons in culture. Morphology and synapses were visualized by confocal imaging of neurons expressing DsRed2 and postsynaptic density protein 95 (PSD95) fused to enhanced green fluorescent protein (GFP). Reducing the extracellular Mg2+ concentration to 0.1 mM for 4 h induced intense synaptic activity, which decreased the number of PSD95-GFP puncta by 45 +/- 13%. Synapse loss was an early event, required activation of N-methyl-D-aspartate receptors, and was mediated by the ubiquitin-proteasome pathway. The cannabinoid receptor full agonist WIN55,212-2 [(R)-(+)-[2,3-dihydro-5-methyl-3-[(4-morpholinyl)-methyl] pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl](1-napthalenyl)-methanone monomethanesulfonate] (EC(50) = 2.5 +/- 0.5 nM) and the partial agonist Delta(9)-tetrahydrocannabinol (THC; EC(50) = 9 +/- 3 nM) inhibited PSD loss in a manner reversed by the CB1 receptor antagonist rimonabant [N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazole-carboxamide]. The protection was mimicked by inhibition of presynaptic Ca2+ channels, and WIN55,212-2 did not prevent PSD loss elicited by direct application of glutamate, suggesting a presynaptic mechanism. Prolonged exposure to WIN55,212-2, but not THC, desensitized the protective effect. Treating cells that had undergone PSD loss with WIN55,212-2 reversed the loss and enabled recovery of a full compliment of synapses. The modulation of synaptic number by acute and prolonged exposure to cannabinoids may account for some of the effects of these drugs on the plasticity, survival, and function of neural networks.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18310474      PMCID: PMC2398764          DOI: 10.1124/jpet.107.131607

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  40 in total

1.  Continual remodeling of postsynaptic density and its regulation by synaptic activity.

Authors:  S Okabe; H D Kim; A Miwa; T Kuriu; H Okado
Journal:  Nat Neurosci       Date:  1999-09       Impact factor: 24.884

Review 2.  Homeostatic plasticity in the CNS: synaptic and intrinsic forms.

Authors:  Niraj S Desai
Journal:  J Physiol Paris       Date:  2003 Jul-Nov

3.  Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids.

Authors:  Alberto Bacci; John R Huguenard; David A Prince
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

4.  Delta(9)-Tetrahydrocannabinol-induced desensitization of cannabinoid-mediated inhibition of synaptic transmission between hippocampal neurons in culture.

Authors:  Daniel J Lundberg; Andrea R Daniel; Stanley A Thayer
Journal:  Neuropharmacology       Date:  2005-09-12       Impact factor: 5.250

5.  Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

Authors:  R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman
Journal:  Ann Neurol       Date:  1991-10       Impact factor: 10.422

6.  Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity.

Authors:  M Shen; S A Thayer
Journal:  Mol Pharmacol       Date:  1998-09       Impact factor: 4.436

7.  Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity.

Authors:  Glenna L Gilbert; Hee Jung Kim; Jon J Waataja; Stanley A Thayer
Journal:  Brain Res       Date:  2006-11-30       Impact factor: 3.252

8.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Authors:  D Panikashvili; C Simeonidou; S Ben-Shabat; L Hanus; A Breuer; R Mechoulam; E Shohami
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

Review 9.  Therapeutic potential of cannabinoids in CNS disease.

Authors:  J Ludovic Croxford
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Reversible loss of dendritic spines and altered excitability after chronic epilepsy in hippocampal slice cultures.

Authors:  M Müller; B H Gähwiler; L Rietschin; S M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

View more
  15 in total

Review 1.  The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders.

Authors:  Ismael Galve-Roperh; Javier Palazuelos; Tania Aguado; Manuel Guzmán
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-09       Impact factor: 5.270

2.  Long-term effects of marijuana use on the brain.

Authors:  Francesca M Filbey; Sina Aslan; Vince D Calhoun; Jeffrey S Spence; Eswar Damaraju; Arvind Caprihan; Judith Segall
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-10       Impact factor: 11.205

3.  Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss.

Authors:  Hee Jung Kim; Angela H Shin; Stanley A Thayer
Journal:  Mol Pharmacol       Date:  2011-06-13       Impact factor: 4.436

4.  Loss of Hyperdirect Pathway Cortico-Subthalamic Inputs Following Degeneration of Midbrain Dopamine Neurons.

Authors:  Hong-Yuan Chu; Eileen L McIver; Ryan F Kovaleski; Jeremy F Atherton; Mark D Bevan
Journal:  Neuron       Date:  2017-09-13       Impact factor: 17.173

5.  HIV gp120-induced neuroinflammation potentiates NMDA receptors to overcome basal suppression of inhibitory synapses by p38 MAPK.

Authors:  Xinwen Zhang; Matthew V Green; Stanley A Thayer
Journal:  J Neurochem       Date:  2019-01-18       Impact factor: 5.372

6.  Lithium increases synapse formation between hippocampal neurons by depleting phosphoinositides.

Authors:  Hee Jung Kim; Stanley A Thayer
Journal:  Mol Pharmacol       Date:  2009-02-02       Impact factor: 4.436

Review 7.  Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.

Authors:  Delphine Psychoyos; K Yaragudri Vinod
Journal:  Drug Test Anal       Date:  2012-08-13       Impact factor: 3.345

8.  Human immunodeficiency virus-1 Tat protein increases the number of inhibitory synapses between hippocampal neurons in culture.

Authors:  Nicholas J Hargus; Stanley A Thayer
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

9.  Cannabinoid receptor-2 and HIV-associated neurocognitive disorders.

Authors:  Vishnudutt Purohit; Rao S Rapaka; Joni Rutter
Journal:  J Neuroimmune Pharmacol       Date:  2014-09       Impact factor: 4.147

Review 10.  The endocannabinoid system in normal and pathological brain ageing.

Authors:  Andras Bilkei-Gorzo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-12-05       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.